TIGIT and cancer: Zhang et al. used Tigitfl/flNcr1iCre/+ mice to show that NK cell-targeted TIGIT deletion led to decreased cancer control in vivo [54]; however, these results contrast with those from another group who observed no difference between TIGIT−/− and WT mice in the same model of B16F10 experimental metastasis [44].